Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 4,195.00
+175.00 (4.35%)
Sep 19, 2025, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 123.76 billion as of September 19, 2025. Its market cap has decreased by -27.33% in one year.
Market Cap
123.76B
Enterprise Value
128.33B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,195.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 123.76B, a decrease of -74.35%. That is a compound annual growth rate of -18.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 123.76B | 15.91% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | 394.74B | 50.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| Yuhan | 8,872.07B |
| SK Biopharmaceuticals | 8,450.00B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |